Adjuvant therapy for pancreatic body or tail adenocarcinoma: a study of the National Cancer Database

BACKGROUND: The optimal multimodality therapy for pancreatic ductal adenocarcinoma in the body or tail of the pancreas (PDAC-BT) is unclear. The purpose of this study was to compare overall 5-year survival between patients treated with adjuvant chemotherapy, adjuvant chemoradiation, and surgery alon...

Descripción completa

Detalles Bibliográficos
Autores principales: Seaton, Max, Hanna, Andrew, Boutros, Cherif, Hanna, Nader
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501493/
https://www.ncbi.nlm.nih.gov/pubmed/31105777
http://dx.doi.org/10.1177/1758835919842438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501493/
https://www.ncbi.nlm.nih.gov/pubmed/31105777
http://dx.doi.org/10.1177/1758835919842438

Ejemplares similares